Phaarmasia Ltd

NSE: BSE: 523620

₹86.59

(-4.99%)

Sat, 07 Mar 2026, 08:57 am

MTF 5xInvest in Phaarmasia Ltd with 5x Leverage Buy with MTF

Market Cap591.15M

PE Ratio3.33

Dividend0

Health Technology

Pharmaceuticals: Major

24.5K

Phaarmasia Price to Sales Ratio (P/S)

D/E EV EV/EBITDA P/B P/CF P/E P/S ROE %

Particulars	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Price to earnings ratio	670.37	1580	1550	535.91	57.85	12.50	61.95	530.83	72.71	43.75	14.79	17.58	54.38	0	0	0	0
Price to book ratio	26.50	19.85	18.16	15.43	1.37	0.60	0.65	1.83	1.02	2.09	0.90	0.71	1.24	1.75	1.48	1.93	2.29
Price to sales ratio	22.93	18.11	3.26	3.49	1.48	0.29	0.45	1.01	0.83	1.24	0.48	0.39	0.86	1.25	0.58	0.65	0.82
Price to cash flow ratio	1220	557.65	71.24	0	100.78	25.44	18.98	81.02	0	28.52	204.61	118.47	67.88	0	24.08	209.56	727.63
Enterprise value	2.47B	1.73B	1.46B	1.21B	102.44M	44.19M	82.9M	213.91M	118.3M	251.17M	115.07M	94.21M	166.33M	209.43M	155.52M	193.77M	196.6M
Enterprise value to EBITDA ratio	247.82	255.59	202.80	115.55	15.71	5.27	8.66	98.49	89.45	38.16	15.87	11.51	0	0	0	0	0
Debt to equity ratio	0.01	0.01	0	0	0	0	0.01	0.01	0.01	0.02	0.01	0.01	0	0	0.02	0.01	0
Return on equity %	0	1.20	1.11	2.80	2.30	4.71	1.36	0.33	1.38	4.77	6.26	4.12	2.31	-12.03	-11.01	-4.91	-16.70

Phaarmasia Ltd Price to Sales Ratio

The Phaarmasia Ltd Price to Sales Ratio is a key financial metric used by investors to evaluate Phaarmasia Ltd's valuation, profitability, and overall financial performance. Tracking the Phaarmasia Ltd Price to Sales Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.

Phaarmasia Ltd (NSE: , BSE: 523620) is currently trading at ₹86.59, with a market capitalization of ₹591.15M. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the Phaarmasia Ltd Price to Sales Ratio is essential for fundamental analysis.

Phaarmasia Ltd Price to Sales Ratio Current Value

The current Phaarmasia Ltd Price to Sales Ratio stands at 0.82.

The latest Phaarmasia Ltd Price to Sales Ratio has increased compared to the previous period, indicating rising valuation or improved investor sentiment.

Phaarmasia Ltd Price to Sales Ratio Historical Trend

The Phaarmasia Ltd Price to Sales Ratio has shown the following historical trend:

2024: 0.82
2023: 0.65
2022: 0.58
2021: 1.25
2020: 0.86

The recent rise in Phaarmasia Ltd Price to Sales Ratio suggests strengthening valuation trends and improving market sentiment.

What Phaarmasia Ltd Price to Sales Ratio Indicates for Investors

The Phaarmasia Ltd Price to Sales Ratio plays a crucial role in understanding the company's financial health and valuation.

The P/S ratio helps evaluate valuation relative to company revenue.

Phaarmasia Ltd Price to Sales Ratio Analysis Summary

The Phaarmasia Ltd Price to Sales Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Phaarmasia Ltd Price to Sales Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.

Regular tracking of Phaarmasia Ltd Price to Sales Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800